FIELD: pharmacology.
SUBSTANCE: invention relates to a diarylthihydantoic derivative of the formula [NC96/RD111] useful for treatment of certain cancers.
.
EFFECT: new compound is obtained, useful for treatment of certain cancers, including hormone-resistant prostate cancer.
6 cl, 25 dwg, 11 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
DIARYLTHIOHYDATOIC COMPOUNDS | 2007 |
|
RU2449993C2 |
DIARYL HYDANTOINS | 2011 |
|
RU2638833C2 |
LOW-MOLECULAR INHIBITORS OF N-TERMINUS ACTIVATION OF ANDROGEN RECEPTOR | 2009 |
|
RU2519948C2 |
THERAPEUTIC AGENTS BASED ON DIGLYCYLYL ETHER DERIVATIVES AND METHODS FOR USING THEM | 2009 |
|
RU2572596C2 |
THIOHYDANTOIN DERIVATIVES USEFUL AS ANDROGEN RECEPTOR ANTAGONISTS | 2012 |
|
RU2598854C2 |
SELECTIVE ANDROGEN RECEPTOR DESTROYING AGENTS (SARD) AND METHODS OF USING THEREOF | 2016 |
|
RU2724103C2 |
NONSTEROID MODULATORS OF ANDROGEN RECEPTOR, METHOD OF PRODUCTION, PHARMECEUTICAL COMPOSITION THEREOF AND USE | 2006 |
|
RU2378250C2 |
SELECTIVE ANDROGEN RECEPTOR DESTROYING (SARD) LIGANDS AND METHODS OF USING THEM | 2016 |
|
RU2689988C2 |
ANDROGEN RECEPTOR SELECTIVE DESTROYING (SARD) LIGANDS AND METHODS OF THEIR USE | 2017 |
|
RU2795431C2 |
CYCLIC N,N'-DIARYLTHIOUREAS OR N,N'-DIARYLUREAS - ANTAGONISTS OF ANDROGEN RECEPTORS, ANTI-CANCER MEDICATION, METHOD OF OBTAINING AND APPLICATION | 2010 |
|
RU2434851C1 |
Authors
Dates
2018-10-05—Published
2012-01-12—Filed